Home/Supreme Court/Teva Pharm. United States, Inc. v. Sandoz, Inc.

Teva Pharm. United States, Inc. v. Sandoz, Inc.

135 S. Ct. 45, 189 L. Ed. 2d 895
Procedural entryThis page is a short order in Teva Pharm. United States, Inc. v. Sandoz, Inc.. Read the opinion of the Court — 135 S. Ct. 831 →
Supreme Court of the United States·Decided October 2, 2014·No. No. 13–854.·Published

Opinion

Motion of petitioners for leave to file Volume 4 of the joint appendix under seal granted. Motion of the Solicitor General for leave to participate in oral argument as amicus curiaeand for divided argument granted.

Free access — add to your briefcase to read the full text and ask questions with AI

Teva Pharm. United States, Inc. v. Sandoz, Inc., 135 S. Ct. 45, 189 L. Ed. 2d 895 (U.S. 2014).

135 S. Ct. 45 (Teva Pharm. United States, Inc. v. Sandoz, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.